Arrevus Competitors and Similar CompaniesClear all
BIoEclipse Therapeutics's competitors and similar companies include NKGen Biotech and Speratum.
 BIoEclipse Therapeutics BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Speratum Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer. | |
Founding Date | Founding Date N/A | Founding Date 2017 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations South San Francisco, US HQ Mountain View, US | Locations Santa Ana, US HQ | Locations HQ |
Employees | Employees 614% decrease | Employees 7316% increase | Employees 9 |
Funding | |||
Latest funding round | Latest funding round $ 7.7m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 2m (over 8 years ago) |
Total funding raised | Total funding raised $ 7.7m | Total funding raised $ 11m | Total funding raised $ 2.8m |
For sources of this data, please see the company profile
View Company Profiles
NKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View companySperatum
HQ
Employees
9
Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer.
View company